Abstract:Background Mutations within the genes PRKN and PINK1 are the leading cause of early onset autosomal recessive Parkinson's disease (PD). However, the genetic cause of most early-onset PD (EOPD) cases still remains unresolved. Long-read sequencing has successfully identified many pathogenic structural variants that cause disease, but this technology has not been widely applied to PD. We recently identified the genetic cause of EOPD in a pair of monozygotic twins by uncovering a complex structural variant that spans over 7 Mb, utilizing Oxford Nanopore Technologies (ONT) long-read sequencing. In this study, we aimed to expand on this and assess whether a second variant could be detected with ONT long-read sequencing in other unresolved EOPD cases reported to carry one heterozygous variant in PRKN or PINK1. Methods ONT long-read sequencing was performed on patients with one reported PRKN/PINK1 pathogenic variant. EOPD patients with an age at onset younger than 50 were included in this study. As a positive control, we also included EOPD patients who had already been identified to carry two known PRKN pathogenic variants. Initial genetic testing was performed using either short-read targeted panel sequencing for single nucleotide variants and multiplex ligation-dependent probe amplification (MLPA) for copy number variants. Results 48 patients were included in this study (PRKN 'one-variant' n = 24, PINK1 'one-variant' n = 12, PRKN 'two-variants' n = 12). Using ONT long-read sequencing, we detected a second pathogenic variant in six PRKN 'one-variant' patients (26%, 6/23) but none in the PINK1 'one-variant' patients (0%, 0/12). Long-read sequencing identified one case with a complex inversion, two instances of structural variant overlap, and three cases of duplication. In addition, in the positive control PRKN 'two-variants' group, we were able to identify both pathogenic variants in PRKN in all the patients (100%, 12/12). Conclusions This data highlights that ONT long-read sequencing is a powerful tool to identify a pathogenic structural variant at the PRKN locus that is often missed by conventional methods. Therefore, for cases where conventional methods fail to detect a second variant for EOPD, long-read sequencing should be considered as an alternative and complementary approach.

Optical genome mapping of structural variants in Parkinson's disease-related induced pluripotent stem cells

Genome-wide association study of copy number variations in Parkinson's disease

High-depth Whole-Genome Sequencing Identifies Structure Variants, Copy Number Variants and Short Tandem Repeats Associated with Parkinson’s Disease

Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells

The Role of Structural Variants in the Genetic Architecture of Parkinson's Disease

Identification of Somatic Structural Variants in Solid Tumors by Optical Genome Mapping

Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease

Optical Genome Mapping of the human reference iPSC line KOLF2.1J reveals new smaller structural variants in neurodevelopmental genes

Generation of naivetropic induced pluripotent stem cells from Parkinson's disease patients for high efficiency genetic manipulation

Optical Genome Mapping as a Potential Routine Clinical Diagnostic Method

iSCORE-PD: an isogenic stem cell collection to research Parkinson’s Disease

Combining optical genome mapping and RNA-seq for structural variants detection and interpretation in unsolved neurodevelopmental disorders

The Utility of Long-Read Sequencing in Diagnosing Genetic Autosomal Recessive Parkinson's Disease: a genetic screening study

Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic Syndromes

Identification of 27 allele-specific regulatory variants in Parkinson’s disease using a massively parallel reporter assay

Precision Medicine in Parkinson's Disease using Induced Pluripotent Stem Cells

Deciphering shared molecular dysregulation across Parkinson's disease variants using a multi-modal network-based data integration and analysis

Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease

Functional genomics elucidates regulatory mechanisms of Parkinson’s disease-associated variants

Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast Cancer